Stability of magnesium sulfate 20% in viaflex bags

Canadian Journal of Hospital Pharmacy

Volumn 61, Issue 5, 2008, Pages 356-357

  Newby, Brandi D ^a   Benes, Cindy ^a   Palmer, Lynne ^a   Cleve, Richard ^a  

^a SURREY MEMORIAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

CONCENTRATION (PARAMETERS); CONTAINER; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; INFUSION PUMP; INTRAVENOUS ADMINISTRATION; LETTER; MEDICATION ERROR; ROOM TEMPERATURE;

EID: 56049106396     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30(3 Suppl 1):S1-S48.
2. BCRCP obstetric guideline 11: hypertension in pregnancy. Vancouver (BC): British Columbia Reproductive Care Program; 2006 Jun [cited 2007 Nov 5]. Available from: http://www.bcphp.ca//sites/bcrcp/files/Guidelines/ Obstetrics/Hypertensionjune2006.pdf
3. Trissel LA. Handbook on injectable drugs. Bethesda (MD): American Society of Health-System Pharmacists; 2007.
4. Simpson KR, Knox GE. Obstetrical accidents involving intravenous magnesium sulfate: recommendations to promote patient safety. MCN Am J Matern Child Nurs 2004;29(3):161-171.
5. Policy for publication of chemical stability study manuscripts. Can J Hosp Pharm 1990;43:1.